Newborn screening for congenital adrenal hyperplasia in Wisconsin.
Beginning in February 1993, newborn screening for 21-hydroxylase deficiency congenital adrenal hyperplasia (21OH-D-CAH) will begin in Wisconsin. This brief review summarizes the pathophysiology of 21OH-D-CAH, its clinical presentation, and the rationale for screening during the neonatal period. An algorithm for interpretation and follow-up of screening results is provided for Wisconsin health care providers.
Allen
D B
DB
University of Wisconsin Children's Hospital.
D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D003430:Cross-Sectional Studies; D005189:False Positive Reactions; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D015997:Neonatal Screening; D014922:Wisconsin / Q000453:epidemiology